Add Company
Join Now

ProteoMediX AG Revenue and Competitors

License our Company Data API

Schlieren,

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • ProteoMediX AG's estimated annual revenue is currently $1.9M per year.(i)
  • ProteoMediX AG's estimated revenue per employee is $155,000

Employee Data

  • ProteoMediX AG has 12 Employees.(i)
  • ProteoMediX AG grew their employee count by -8% last year.

ProteoMediX AG's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$99.4M45840%N/AN/A
#2
$20.6M13322%N/AN/A
#3
$156.1M146-70%$145MN/A
#4
$3.5M45-25%$150MN/A
#5
$1.6M210%$459.5MN/A
#6
$67.3M31016%$180.7MN/A
#7
$8.5M55-2%N/AN/A
#8
$256.3M10259%$168.5MN/A
#9
$2.8M18-33%N/AN/A
#10
$9.1M59-9%N/AN/A
Add Company

What Is ProteoMediX AG?

Proteomedix enables personalized medicine by developing non-invasive diagnostic tests to detect and assess the prognosis of cancer, as well as to match patients with safer and more effective therapies. The first product is a blood-based test for the early diagnosis of prostate cancer. The main benefit of this test is a significantly higher accuracy compared to today's clinical standard (blood-based PSA test). This reduces unnecessary biopsies and thus results in significant cost savings for the healthcare system and less discomfort for the patient.

keywords:N/A

N/A

Total Funding

12

Number of Employees

$1.9M

Revenue (est)

-8%

Employee Growth %

N/A

Valuation

N/A

Accelerator

ProteoMediX AG News

2022-04-17 - Digital Pathology Market Study Offering Insights on Latest ...

... Market Study Offering Insights on Latest Advancements, Trends and Analysis to 2029 |Hamamatsu Photonics, Apollo Pacs, Definiens AG.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.6M1713%N/A
#2
$2.6M17-54%$105M
#3
$2.9M294%N/A
#4
$5.3M34-3%N/A
#5
$4.1M35N/AN/A